Educating peers at programs and symposia about the legal and regulatory issues confronted by industry is important to Gardner Law. Topics covered relate to off-label promotion and lawful dissemination methods, social media use, implementing effective compliance programs and performing compliance audits, mobile medical applications, Sunshine reporting, enforcement (FDA, OIG, & DOJ), and the FDA approval process.
Providing quotes to the press regarding regulatory developments that impact FDA-regulated companies is important to the firm. Quotes from Mark Gardner in the past have been featured in the StarTribune, FDA News, Qmed, MD+DI (UBM Canon), Medical Device Daily (Thompson Reuters), MedCity News, Orthopedics This Week, and Medical Alley, among others.
Gardner Law periodically writes about important legal and regulatory issues that impact FDA-regulated industries. You can view past publications by clicking below. Sign up for News Alerts by scrolling to the bottom of the page.